EP1011654A4 - METHODS FOR MODULATING CELL ACTIVITY - Google Patents
METHODS FOR MODULATING CELL ACTIVITYInfo
- Publication number
- EP1011654A4 EP1011654A4 EP98941157A EP98941157A EP1011654A4 EP 1011654 A4 EP1011654 A4 EP 1011654A4 EP 98941157 A EP98941157 A EP 98941157A EP 98941157 A EP98941157 A EP 98941157A EP 1011654 A4 EP1011654 A4 EP 1011654A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cellular activity
- modulating cellular
- modulating
- activity
- cellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Cardiology (AREA)
- Food Science & Technology (AREA)
- Vascular Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Heart & Thoracic Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPO900297 | 1997-09-08 | ||
AUPO9002A AUPO900297A0 (en) | 1997-09-08 | 1997-09-08 | A method of modulating cellular activity |
PCT/AU1998/000730 WO1999012533A1 (en) | 1997-09-08 | 1998-09-08 | A method of modulating cellular activity |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1011654A1 EP1011654A1 (en) | 2000-06-28 |
EP1011654A4 true EP1011654A4 (en) | 2004-09-15 |
Family
ID=3803288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98941157A Withdrawn EP1011654A4 (en) | 1997-09-08 | 1998-09-08 | METHODS FOR MODULATING CELL ACTIVITY |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1011654A4 (ja) |
JP (1) | JP4570246B2 (ja) |
AU (2) | AUPO900297A0 (ja) |
CA (1) | CA2302838C (ja) |
WO (1) | WO1999012533A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1192247B9 (en) | 1999-05-13 | 2007-10-31 | Johnson & Johnson Pharmaceutical Research and Development LLC | Sphingosine kinase enzyme |
AUPQ744700A0 (en) * | 2000-05-11 | 2000-06-01 | Medvet Science Pty. Ltd. | A method of treatment and agents useful for same |
EP1195604A1 (en) * | 2000-09-29 | 2002-04-10 | Warner-Lambert Company | Methods and compositions for screening modulators of lipid kinases |
US6610534B2 (en) * | 2000-10-05 | 2003-08-26 | Novartis Ag | Induction of blood vessel formation through administration of polynucleotides encoding sphingosine kinases |
NZ529983A (en) * | 2001-06-07 | 2006-09-29 | Medvet Science Pty Ltd | Sphingosine kinase interacts with TRAF2 and modulates tumor necrosis factor-induced cellular activity |
EP1499343A4 (en) * | 2002-03-28 | 2005-12-28 | Medvet Science Pty Ltd | METHOD FOR MODULATING CELL ACTIVITY |
CA2502257A1 (en) * | 2002-10-14 | 2004-04-29 | Jennifer Ruth Gamble | A method of modulating endothelial cell activity by modulating the functional levels level of sphingosine kinase |
EP1481680A1 (en) | 2003-05-30 | 2004-12-01 | Aventis Pharma Deutschland GmbH | Use of S1P |
MXPA06014888A (es) * | 2004-06-15 | 2007-03-21 | Medvet Science Pty Ltd | Metodos para modular actividad celular que involucra esfingosina cinasa y agentes para los mismos, y variantes de esfingosina cinasa. |
AU2005253643B2 (en) * | 2004-06-15 | 2011-12-01 | Medvet Science Pty. Ltd. | Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants |
JP2008528450A (ja) * | 2005-01-21 | 2008-07-31 | メドベット サイエンス ピーティーワイ. リミティッド | 細胞損傷の治療法 |
US8747844B2 (en) | 2010-07-30 | 2014-06-10 | Saint Louis University | Methods of treating pain |
WO2017015334A1 (en) | 2015-07-21 | 2017-01-26 | Saint Louis University | Compositions and methods for diagnosing and treating endometriosis-related infertility |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4766111A (en) * | 1985-10-31 | 1988-08-23 | Trustees Of Boston University | Lipids with plasmin inhibitory properties |
WO1988009345A1 (en) * | 1987-05-20 | 1988-12-01 | The Rogosin Institute | Reconstituted hdl particles and uses thereof |
US5190876A (en) * | 1988-12-27 | 1993-03-02 | Emory University | Method of modifying cellular differentiation and function and compositions therefor |
CA2007507C (en) * | 1989-02-03 | 1998-05-19 | Yasuyuki Igarashi | Sphingosine and n-methyl-sphingosine as inhibitor of cell growth |
US5466716A (en) * | 1990-12-31 | 1995-11-14 | The Biomembrane Institute | Liposomal trimethylsphingosine |
JP3768525B2 (ja) * | 1993-07-23 | 2006-04-19 | オンコメンブラン・インク | N,n,n−トリメチルスフィンゴシン誘導体 |
DE69534438T2 (de) * | 1994-12-29 | 2006-06-29 | The Regents Of The University Of California, Oakland | Verbindungen für Ceramid-vermittelter Signalübertragung |
US5677189A (en) * | 1995-06-29 | 1997-10-14 | Oncomembrane, Inc. | Method for quantifying sphingosine and for diagnosing platelet activation |
JPH09176083A (ja) * | 1995-12-28 | 1997-07-08 | Sankyo Co Ltd | 新規化合物f−12509a |
-
1997
- 1997-09-08 AU AUPO9002A patent/AUPO900297A0/en not_active Abandoned
-
1998
- 1998-09-08 JP JP2000510431A patent/JP4570246B2/ja not_active Expired - Lifetime
- 1998-09-08 WO PCT/AU1998/000730 patent/WO1999012533A1/en active IP Right Grant
- 1998-09-08 CA CA2302838A patent/CA2302838C/en not_active Expired - Lifetime
- 1998-09-08 AU AU89658/98A patent/AU757358B2/en not_active Expired
- 1998-09-08 EP EP98941157A patent/EP1011654A4/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
CA2302838C (en) | 2010-03-16 |
AUPO900297A0 (en) | 1997-10-02 |
EP1011654A1 (en) | 2000-06-28 |
JP2001515857A (ja) | 2001-09-25 |
WO1999012533A1 (en) | 1999-03-18 |
AU8965898A (en) | 1999-03-29 |
AU757358B2 (en) | 2003-02-20 |
CA2302838A1 (en) | 1999-03-18 |
JP4570246B2 (ja) | 2010-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL330064A1 (en) | Method of obtaining a catalyst | |
AP9500756A0 (en) | Modulation of cellular activity | |
IL133822A0 (en) | Aroylpiperazines for modulating sexual activity | |
GB9714227D0 (en) | A method of scheduling calls | |
EP1039890A4 (en) | METFORMIN SALTS AND METHOD | |
PL335504A1 (en) | Method of obtaining a catalytic composition | |
HU9702242D0 (en) | Inozitol-glykanes of inzulin-like activity | |
ZA954437B (en) | Method of operating of a radio system | |
EP1011654A4 (en) | METHODS FOR MODULATING CELL ACTIVITY | |
GB9702290D0 (en) | A handset and method of operation thereof | |
GB2322767B (en) | A method of transmitting call information | |
GB2327175B (en) | Method of operating a cellular network | |
AU8742398A (en) | Method of reducing a schiff base | |
ZA9810471B (en) | New method | |
KR100714319B1 (ko) | 파이프 하우스의 구축 방법 | |
GB2325438B (en) | Method of printing | |
GB2323279B (en) | A method of preservation | |
AU2003204254A1 (en) | A Method of Modulating Cellular Activity | |
GB2320911B (en) | Method of making a mat | |
ZA957223B (en) | Modulation of cellular activity | |
GB2327296B (en) | Method of making a FET | |
GB9707251D0 (en) | Novel method and compounds | |
GB2360805B (en) | Method of completing a well | |
GB2332599B (en) | Cellular communication system and method therefor | |
ZA9810044B (en) | A method of construction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000404 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: JOHNSON & JOHNSON RESEARCH PTY LIMITED |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH AND |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040730 |
|
17Q | First examination report despatched |
Effective date: 20070725 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20150106 |